Authors:
COHEN YC
HASSINBAER S
BARISHEV R
GOLDHAMMER Y
MOSES B
Citation: Yc. Cohen et al., MS-CANE - COMPUTER-AIDED NEUROLOGICAL EVALUATION OF MULTIPLE-SCLEROSIS PATIENTS, BASED ON KURTZKES EXPANDED DISABILITY STATUS SCALE, Neurology, 50(4), 1998, pp. 4040-4040
Authors:
MENOLD MM
SADEH M
LENNON F
BLATT I
GOLDHAMMER Y
YAMAOKA LH
VANCE JM
PERICAKVANCE MA
Citation: Mm. Menold et al., EVIDENCE FOR GENETIC-HETEROGENEITY SUPPORTS CLINICAL DIFFERENCES IN CONGENITAL MYASTHENIC SYNDROMES, Human heredity, 48(6), 1998, pp. 325-332
Authors:
MENOLD MM
LENNON F
SADEH M
GOLDHAMMER Y
BLATT I
YAMAOKA LH
VANCE JM
PERICAKVANCE MA
Citation: Mm. Menold et al., EVIDENCE FOR GENETIC-HETEROGENEITY SUPPORTS CLINICAL DIFFERENCES IN CONGENITAL MYASTHENIC SYNDROMES (CMS), American journal of human genetics, 61(4), 1997, pp. 1667-1667
Authors:
BARAK Y
ACHIRON A
GABBAY U
GILAD R
SAROVAPINHAS I
GOLDHAMMER Y
GORNISH M
NOY S
ELIZUR A
Citation: Y. Barak et al., NEUROPSYCHIATRIC ASSESSMENT AS A SECONDARY OUTCOME MEASURE IN A MULTIPLE-SCLEROSIS IVIG TRIAL, Israel journal of psychiatry and related sciences, 33(4), 1996, pp. 266-267
Authors:
CHAPMAN J
BENISRAEL J
GOLDHAMMER Y
KORCZYN AD
Citation: J. Chapman et al., THE RISK OF DEVELOPING CREUTZFELDT-JAKOB-DISEASE IN SUBJECTS WITH THEPRNP GENE CODON-200 POINT MUTATION, Neurology, 44(9), 1994, pp. 1683-1686
Citation: Y. Goldhammer et al., AN ISRAELI FAMILY WITH GERSTMANN-STRAUSSLER-SCHEINKER DISEASE MANIFESTING THE CODON-102 MUTATION IN THE PRION PROTEIN GENE, Neurology, 43(12), 1993, pp. 2718-2719